@2024 Afarand., IRAN
ISSN: 2383-3483 Journal of Police Medicine 2018;7(3):135-140
ISSN: 2383-3483 Journal of Police Medicine 2018;7(3):135-140
Disruption of the Aldosterone Hormone Secretion: Criminology Study
ARTICLE INFO
Article Type
Analytic ReviewAuthors
Mohammad Salehi Darani S. (*)(*) Department of Law, Payam Noor University, Tehran, Iran
Correspondence
Address: Central Organization of Payam Noor University, Nakhl Street, Naft Town, Artesh Boulevard, Minicity Town, Tehran. Postal code: 193954697Phone: +98 (31) 57228247
Fax: +98 (31) 852238784
saforam_1364@yahoo.com
Article History
Received: May 22, 2018Accepted: June 24, 2018
ePublished: June 29, 2018
ABSTRACT
Aims
One of the most important issues that the current communities are involved in is the issue of delinquency. Biologically, one of the important issues in the occurrence of a crime could be the secretion of the adrenal glands. One of the important factors in creating the person's personality is the type of functioning of the adrenal glands and its effects on other glands and manifests itself in the physical and mental state of the individual. The aldosterone hormone produces hormones that regulate the level of the body's minerals. This article was aimed at investigating the rate of reduction of person's alertness with disruption of secretion of the aldosterone hormone.
Conclusion Disruption of the aldosterone hormone secretion is associated with problems such as hypokalemia, hyperkalemia, failure or infection of kidney, high blood pressure and high blood sugar, or Addison. These problems are significant in terms of criminology; for example, in hypokalemia person's heartbeat is irregular, temporary anesthetic and muscle contraction happens and finally the person goes out of physical and psychological balance. Due to the relative deprivation of perception and alertness in these circumstances, grounds for committing a crime are created. Criminology of high blood pressure is also important because high blood pressure can lead to severe cardiac and brain problems and alertness. Since these diseases have an internal and individual aspect, the guilty does not realize his problem and usually does not cure his illness to defend himself. Therefore, in the event that a person commits a crime due to an abnormality in the secretion of the aldosterone secretion and the other complications mentioned, he should be recognized as having a semi-consistent criminal responsibility. In addition, the total of these physical factors is responsible for other mental illnesses, so that the person may behave abusive behaviors such as attack and aggression.
Conclusion Disruption of the aldosterone hormone secretion is associated with problems such as hypokalemia, hyperkalemia, failure or infection of kidney, high blood pressure and high blood sugar, or Addison. These problems are significant in terms of criminology; for example, in hypokalemia person's heartbeat is irregular, temporary anesthetic and muscle contraction happens and finally the person goes out of physical and psychological balance. Due to the relative deprivation of perception and alertness in these circumstances, grounds for committing a crime are created. Criminology of high blood pressure is also important because high blood pressure can lead to severe cardiac and brain problems and alertness. Since these diseases have an internal and individual aspect, the guilty does not realize his problem and usually does not cure his illness to defend himself. Therefore, in the event that a person commits a crime due to an abnormality in the secretion of the aldosterone secretion and the other complications mentioned, he should be recognized as having a semi-consistent criminal responsibility. In addition, the total of these physical factors is responsible for other mental illnesses, so that the person may behave abusive behaviors such as attack and aggression.
CITATION LINKS
[1]Freund BJ, Shizuru EM, Hashiro GM, Claybaugh JR. Hormonal, electrolyte, and renal response to exercise are intensity dependent. J Apple Physiol. 1991;70(2):900-6.
[2]Montain SJ, Larid JE, Latzka WA, Sawka MN. Aldostrone and vasopressin responses in the heat:hydration level and exercise intensity effects. Med Sci Sports Exerc. 1997;29(5):661-8.
[3]Funder JW. Aldosterone and mineralocorticoid receptors: physiology and pathophysiology. Int J Mol Sci. 2017;18(5):1032.
[4]Rohani AH. Physiology of nerves and endocrine glands. Tehran: Samt Publishing; 2006. [Persian]
[5]Bradley WG. Neurology in clinical practice. Philadelphia: Butterworth Heinemann; 2002.
[6]Merritt HH, Rowland LP. Merritt's neurology. Philadelphia: Lippincott Williams & Wilkins; 2000.
[7]Gilroy J. Basic neurology. New York: McGraw-Hill; 2000.
[8]Adams RD, Ropper AH, Victor M, Samuels MA. Principle of neurology, 5th edition. New York: McGraw-Hill; 1993.
[9]Hatta K. Abnormal physiological conditions due to hypersympathetic activity in psychiatric emergency patients. Gen Hosp Psychiatry. 2005;27(6):454-6.
[10]Beladi Mosavi SS, Layegh P, Zeraaty AA, Tamadon M. Diabets and the treatment in patients with renal failure. Med J Mashhad Univ Med Sci. 2014;57(7):866-73.
[11]Roxburgh A, Degenhardt L. Characteristics of drug-related hospital separations in Australia. Drug Alcohol Depend. 2008;92(1-3):149-55.
[12]Grossman RA, Hamilton RW, Morse BM, Penn AS, Goldberg M. Nontraumatic rhabdomyolysis and acute renal failure. N Engl J Med. 1974;291(16):807-11.
[13]Moghadamnia AA, Abdollahi M. An epidemiological study of poisoning in northern Islamic Republic of Iran. East Mediterr Health J. 2002;8(1):88-94. [Persian]
[14]Shah NG, Lathrop SL, Reichard RR, Landen MG. Unintentional drug overdose death trends in New Mexico, USA, 1990–2005: combinations of heroin, cocaine, prescription opioids and alcohol. Addiction. 2008;103(1):126-36.
[15]Abdollahi M, Jalali N, Sabzevari O, Hoseini R, Ghanea T. A restrospective study of poisoning in Tehran. J Toxicol: Clin Toxicol. 1997;35(4):387-93. [Persian]
[16]Moghaddamnia A, Halaji Sani S. Study of acute poisoning in Ramsar. J Qazvin Univ Med Sci. 1999;3(2):43-9. [Persian]
[17]Correia MA. Drug biotransformation. In: Katzung BG, Trevor AJ, Masters SB, editors. Basic and clinical pharmacology. New York: McGraw-Hil; 2007. pp. 50-63.
[18]Alexander RW, Schlant RC, Fuster V. Hurst's the heart, arteries and veins. New York: McGraw-Hill; 1998.
[19]Bonow RO, Mann DL, Zipes DP, Libby P. Braunwald's Heart Disease E-Book: A Textbook of Cardiovascular Medicine. Philadelphia: Elsevier Health Sciences; 2011.
[20]MahmoudAbadi A. Chronic and acute renal failure and dialysis. Tehran: Kerdegari Publishing; 1386. [Persian]
[21]Chaman R, Yunesian M, Hajimohamadi A, Taramsari MG. Investigating hypertension prevalence and some of its influential factors in an ethnically variant rural sample. Knowl Health. 2008;3(3-4):39-42. [Persian]
[22]Haghdoost AA, Sadeghirad B, Rezazadeh kermani M. Epidemiology and heterogeneity of hypertension in Iran: a systematic review. Arch Iran Med. 2008;11(4):444-52. [Persian]
[23]Mofid A, Sayedalinaghi SA, Zandieh S, Mofid R, Khanlari M. Diabetes disease: A comprehensive guide to diagnosis, monitoring and treatment. Tehran: Osaneh; 2009. [Persian]
[24]Dusek JA, Hibberd PL, Buczynski B, Chang BH, Dusek KC, Johnston JM, et al. Stress management versus lifestyle modification on systolic hypertension and medication elimination: A randomized trial. J Altern Complement Med. 2008;14(2):129-38.
[25]Stephens I. Medical yoga therapy. Children. 2017;4(2):12-32.
[26]Björntorp P, Holm G, Rosmond R. Hypothalamic arousal, insulin resistance and type 2 diabetes mellitus. Diabet Med. 1999;16(5):373-83.
[27]Barth J, Schumacher M, Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med. 2004;66(6):802-13.
[28]Block Bern IM. Dealing with depression and its treatment. Shams G ,translator. Tehran: Roshd; 2012. [Persian]
[29]Imel ZE, Malterer MB, McKay KM, Wampold BE. A meta-analysis of psychotherapy and dysthymia. J Affect Disord. 2008;110(3):197-206.
[30]Kennia M. Criminal Psychology. Tehran: Rushd Publishing; 2004.
[31]Calvin M, Kunin MD. Does kidney infection cause renal failure. Ann Rev Med. 1985;36:165-76.
[32]Razaghi M, Tajeddin E, Alebouyeh M, Rajabi Bazl M, Zali MR. Frequency of β-lactamase producing isolates of Escherichia coli and their diversity in enzyme activities among the resistance isolates from patients with diarrhea and nosocomial infections in Tehran, Iran. Koomesh. 2014;15(2):197-205. [Persian]
[33]Allan R, Ronald MD. Optimal duration of treatment for kidney infection. Ann Intern Med. 1987;106(3):467-8.
[34]Ghassemi K, Esteghamati M, Rahmati MB, Hamedi Y, Nazemi A, Molavi MA, et al. Relation of symptomatic idiopathic hypercalciuria with urinary tract infection in patients attending to children hospital. Asia J Med Pharm Res. 2013;3(4):102-4. [Persian]
[35]Brooke AM, Monson JP. Addison's disease. Medicine. 2017;45(8):492-6.
[36]Gabrilove JL, Seman AT, Sabet R, Mitty HA, Nicolis GL. Virilizing adrenal adenoma with studies on the steroid content of the adrenal venous effluent and a review of the literature. Endocr Rev. 1981;2(4):462-70.
[37]Bratlandab E, Eysteien S, Husebyeab. Cellular immunity and immunopathology in autoimmune Addison's disease. Mol Cell Endocrinol. 2011;336(1–2):180-90.
[38]Grace E, Ziem MD. Multiple chemical sensivity: treatment and follow up with avoidance and control of chemical exposure. Toxicol Ind Health. 1992;8(4):73-86.
[39]Henry M, Wolf PSA, Ross L, Thomas KGF. Poor quality of life, depressed mood, and memory impairment may be mediated by sleep disruption in patients with Addison's disease. Physiol Behav. 2015;151:379-85.
[2]Montain SJ, Larid JE, Latzka WA, Sawka MN. Aldostrone and vasopressin responses in the heat:hydration level and exercise intensity effects. Med Sci Sports Exerc. 1997;29(5):661-8.
[3]Funder JW. Aldosterone and mineralocorticoid receptors: physiology and pathophysiology. Int J Mol Sci. 2017;18(5):1032.
[4]Rohani AH. Physiology of nerves and endocrine glands. Tehran: Samt Publishing; 2006. [Persian]
[5]Bradley WG. Neurology in clinical practice. Philadelphia: Butterworth Heinemann; 2002.
[6]Merritt HH, Rowland LP. Merritt's neurology. Philadelphia: Lippincott Williams & Wilkins; 2000.
[7]Gilroy J. Basic neurology. New York: McGraw-Hill; 2000.
[8]Adams RD, Ropper AH, Victor M, Samuels MA. Principle of neurology, 5th edition. New York: McGraw-Hill; 1993.
[9]Hatta K. Abnormal physiological conditions due to hypersympathetic activity in psychiatric emergency patients. Gen Hosp Psychiatry. 2005;27(6):454-6.
[10]Beladi Mosavi SS, Layegh P, Zeraaty AA, Tamadon M. Diabets and the treatment in patients with renal failure. Med J Mashhad Univ Med Sci. 2014;57(7):866-73.
[11]Roxburgh A, Degenhardt L. Characteristics of drug-related hospital separations in Australia. Drug Alcohol Depend. 2008;92(1-3):149-55.
[12]Grossman RA, Hamilton RW, Morse BM, Penn AS, Goldberg M. Nontraumatic rhabdomyolysis and acute renal failure. N Engl J Med. 1974;291(16):807-11.
[13]Moghadamnia AA, Abdollahi M. An epidemiological study of poisoning in northern Islamic Republic of Iran. East Mediterr Health J. 2002;8(1):88-94. [Persian]
[14]Shah NG, Lathrop SL, Reichard RR, Landen MG. Unintentional drug overdose death trends in New Mexico, USA, 1990–2005: combinations of heroin, cocaine, prescription opioids and alcohol. Addiction. 2008;103(1):126-36.
[15]Abdollahi M, Jalali N, Sabzevari O, Hoseini R, Ghanea T. A restrospective study of poisoning in Tehran. J Toxicol: Clin Toxicol. 1997;35(4):387-93. [Persian]
[16]Moghaddamnia A, Halaji Sani S. Study of acute poisoning in Ramsar. J Qazvin Univ Med Sci. 1999;3(2):43-9. [Persian]
[17]Correia MA. Drug biotransformation. In: Katzung BG, Trevor AJ, Masters SB, editors. Basic and clinical pharmacology. New York: McGraw-Hil; 2007. pp. 50-63.
[18]Alexander RW, Schlant RC, Fuster V. Hurst's the heart, arteries and veins. New York: McGraw-Hill; 1998.
[19]Bonow RO, Mann DL, Zipes DP, Libby P. Braunwald's Heart Disease E-Book: A Textbook of Cardiovascular Medicine. Philadelphia: Elsevier Health Sciences; 2011.
[20]MahmoudAbadi A. Chronic and acute renal failure and dialysis. Tehran: Kerdegari Publishing; 1386. [Persian]
[21]Chaman R, Yunesian M, Hajimohamadi A, Taramsari MG. Investigating hypertension prevalence and some of its influential factors in an ethnically variant rural sample. Knowl Health. 2008;3(3-4):39-42. [Persian]
[22]Haghdoost AA, Sadeghirad B, Rezazadeh kermani M. Epidemiology and heterogeneity of hypertension in Iran: a systematic review. Arch Iran Med. 2008;11(4):444-52. [Persian]
[23]Mofid A, Sayedalinaghi SA, Zandieh S, Mofid R, Khanlari M. Diabetes disease: A comprehensive guide to diagnosis, monitoring and treatment. Tehran: Osaneh; 2009. [Persian]
[24]Dusek JA, Hibberd PL, Buczynski B, Chang BH, Dusek KC, Johnston JM, et al. Stress management versus lifestyle modification on systolic hypertension and medication elimination: A randomized trial. J Altern Complement Med. 2008;14(2):129-38.
[25]Stephens I. Medical yoga therapy. Children. 2017;4(2):12-32.
[26]Björntorp P, Holm G, Rosmond R. Hypothalamic arousal, insulin resistance and type 2 diabetes mellitus. Diabet Med. 1999;16(5):373-83.
[27]Barth J, Schumacher M, Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med. 2004;66(6):802-13.
[28]Block Bern IM. Dealing with depression and its treatment. Shams G ,translator. Tehran: Roshd; 2012. [Persian]
[29]Imel ZE, Malterer MB, McKay KM, Wampold BE. A meta-analysis of psychotherapy and dysthymia. J Affect Disord. 2008;110(3):197-206.
[30]Kennia M. Criminal Psychology. Tehran: Rushd Publishing; 2004.
[31]Calvin M, Kunin MD. Does kidney infection cause renal failure. Ann Rev Med. 1985;36:165-76.
[32]Razaghi M, Tajeddin E, Alebouyeh M, Rajabi Bazl M, Zali MR. Frequency of β-lactamase producing isolates of Escherichia coli and their diversity in enzyme activities among the resistance isolates from patients with diarrhea and nosocomial infections in Tehran, Iran. Koomesh. 2014;15(2):197-205. [Persian]
[33]Allan R, Ronald MD. Optimal duration of treatment for kidney infection. Ann Intern Med. 1987;106(3):467-8.
[34]Ghassemi K, Esteghamati M, Rahmati MB, Hamedi Y, Nazemi A, Molavi MA, et al. Relation of symptomatic idiopathic hypercalciuria with urinary tract infection in patients attending to children hospital. Asia J Med Pharm Res. 2013;3(4):102-4. [Persian]
[35]Brooke AM, Monson JP. Addison's disease. Medicine. 2017;45(8):492-6.
[36]Gabrilove JL, Seman AT, Sabet R, Mitty HA, Nicolis GL. Virilizing adrenal adenoma with studies on the steroid content of the adrenal venous effluent and a review of the literature. Endocr Rev. 1981;2(4):462-70.
[37]Bratlandab E, Eysteien S, Husebyeab. Cellular immunity and immunopathology in autoimmune Addison's disease. Mol Cell Endocrinol. 2011;336(1–2):180-90.
[38]Grace E, Ziem MD. Multiple chemical sensivity: treatment and follow up with avoidance and control of chemical exposure. Toxicol Ind Health. 1992;8(4):73-86.
[39]Henry M, Wolf PSA, Ross L, Thomas KGF. Poor quality of life, depressed mood, and memory impairment may be mediated by sleep disruption in patients with Addison's disease. Physiol Behav. 2015;151:379-85.